Abstract

Hemophilia A (HA) is an X-linked recessive bleeding disorder with a high rate of genetic heterogeneity. The present study was conducted on a large cohort of Iranian HA patients and data obtained from databases. A total of 622 Iranian HA patients from 329 unrelated families who had been referred to a medical genetics laboratory in Tehran from 2005 to 2019, were enrolled in this retrospective, observational study. Genetic screening of pathogenic variants of the F8 gene was performed using inverse shifting PCR, direct sequencing, and multiplex ligation-dependent amplification (MLPA). Point mutation frequencies in different exons were analyzed for our samples as well as 6031 HA patients whose data were recorded in a database. A total of 144 different pathogenic or likely pathogenic variants including 29 novel variants were identified. A strategy to decrease costs of genetic testing of HA was suggested based on this finding. This study provides comprehensive information on F8 pathogenic/likely pathogenic variants in Iranian HA patients which improves the spectrum of causative mutations and can be helpful to clinicians and medical geneticists in counseling and molecular diagnosis of HA.

Highlights

  • Hemophilia A (HA, OMIM: 306 700) is an X-linked hereditary bleeding disorder with an incidence of 1: 5000 male births

  • The FVIII is a plasma glycoprotein that participates in the blood coagulation cascade as a cofactor of factor IX (FIX) serine protease

  • F8 pathogenic variants were identified in 324 families, representing a detection rate of 98.5%

Read more

Summary

Introduction

Hemophilia A (HA, OMIM: 306 700) is an X-linked hereditary bleeding disorder with an incidence of 1: 5000 male births. HA is caused by a deficiency in coagulation factor VIII clotting activity; according to the baseline activity of this factor, HA is classified as severe (< 1%), moderate (1–5%) or mild (> 5%).[1] The FVIII is a plasma glycoprotein that participates in the blood coagulation cascade as a cofactor of factor IX (FIX) serine protease This protein has a domain structure of A1-A2-B-A3-C1-C2 encoded by the F8 gene (F8, OMIM: 300 841). Arch Iran Med. 2021;24(12):887-896. doi: 10.34172/ aim.2021.133

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call